The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
about
In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.The role of CD147 expression in prostate cancer: a systematic review and meta-analysis.CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis.Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.VEGF inhibitors and prostate cancer therapyRenal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis.Transporter molecules influence the gene expression in HeLa cells.Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells.Development of an in vitro model to study the impact of BMP-2 on metastasis to bone.Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.Comprehensive proteomic analysis of human bile.Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma.EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
P2860
Q28482047-9843B3D4-ED6F-438E-B18C-22B28E91CD5BQ33506186-DE74EE03-9AC4-4AA1-B14C-A20D51FF5F46Q33970452-5C5F509B-96B4-4444-806C-3E3ED09F4C6FQ36106474-6D4F41D9-292E-42F4-ADDB-3318C9C0B488Q36148171-79F6C5DB-30BB-47F5-9027-7F1D1949F444Q36475792-B6361662-44AB-448B-AEC7-E31CF579476DQ37264085-D7AE9A19-179A-443F-BFED-13D82955681AQ37368492-8F15A058-9ECE-45DB-BA2F-382B470EFDD4Q38510992-7C6B0217-0212-4F78-A120-CEEA233FC2A4Q39619019-544629BE-3C28-4F70-BA5A-F28A92C6F13EQ39652024-9472EFF1-77A1-4C54-B54C-2B5EBC4CE6A2Q39663662-42DDA435-859C-4F3F-9350-EC35F51CCE0EQ39683396-3A817F5D-6015-46E4-9203-89F4CE40DC30Q46103336-3A76D454-AB8D-4446-9454-643254E71FB7Q46116410-48E1D2C9-3175-47DD-9DAB-0D0341974D52Q50202965-0AA5FD14-A5D8-483D-8E36-4A8FB9C6864A
P2860
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The role of extracellular matr ...... n prostate cancer progression.
@en
type
label
The role of extracellular matr ...... n prostate cancer progression.
@en
prefLabel
The role of extracellular matr ...... n prostate cancer progression.
@en
P2093
P2860
P1476
The role of extracellular matr ...... n prostate cancer progression.
@en
P2093
Elizabeth A Kingsley
Michele C Madigan
Paul J Cozzi
Warick J Delprado
P2860
P2888
P304
P356
10.1007/S00262-008-0473-X
P577
2008-02-14T00:00:00Z
P6179
1049795050